Condition
Recurrent Miscarriages
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07724405Phase 2Recruiting
Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
NCT00180804CompletedPrimary
Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages
NCT02746588CompletedPrimary
Description of the Uterine Cavity in Patients With Recurrent Miscarriages
NCT03156491CompletedPrimary
Maternal Embryo Interaction in Recurrent Miscarriages
Showing all 4 trials